New Antibiotic to Treat Patients With Community-Acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) - Related Studies

New Antibiotic to Treat Patients With Community-Acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

This study has been completed.

Study NCT00035269. Last updated on July 2, 2007. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pneumonia, Pneumococcal
		Community Acquired Infections
		Gram-Positive Bacterial Infections

2	Additional conditions recognized in this trial
		Bacterial Infections
		Communicable Diseases
		Community-Acquired Infections
		Infection
		Pneumonia

3	More general conditions related to this trial
		Lung Diseases
		Pneumococcal Infections
		Pneumonia, Bacterial
		Respiratory Tract Diseases
		Respiratory Tract Infections
		Streptococcal Infections

4	Interventions listed in this trial
		Antibiotic

5	Sponsors listed in this trial
		Pfizer